5-carboxyfluorescein diacetate has been researched along with l 660,711 in 2 studies
| Studies (5-carboxyfluorescein diacetate) | Trials (5-carboxyfluorescein diacetate) | Recent Studies (post-2010) (5-carboxyfluorescein diacetate) | Studies (l 660,711) | Trials (l 660,711) | Recent Studies (post-2010) (l 660,711) |
|---|---|---|---|---|---|
| 41 | 0 | 13 | 45 | 0 | 12 |
| Protein | Taxonomy | 5-carboxyfluorescein diacetate (IC50) | l 660,711 (IC50) |
|---|---|---|---|
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 9.3 | |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 8 | |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | 2.9 | |
| Bile salt export pump | Homo sapiens (human) | 3.515 | |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 2.9733 | |
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | 2.62 | |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | 7 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 6.4 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 4.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
2 other study(ies) available for 5-carboxyfluorescein diacetate and l 660,711
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |